Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,502 Infectious Disease
clinical trials

Cytomegalovirus Infections Clinical Trial
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling, Phase III
Updated: 3/2/2016
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling, Phase III
Updated: 3/2/2016
1601
mi
from 02139
Houston, TX
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling, Phase III
Updated: 3/2/2016
1047
mi
from 02139
Iowa City, IA
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling, Phase III
Updated: 3/2/2016
1245
mi
from 02139
Kansas City, MO
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling, Phase III
Updated: 3/2/2016
2687
mi
from 02139
Stanford, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 6/21/2017
643
mi
from 02139
Ann Arbor, MI
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 6/21/2017
1378
mi
from 02139
Baton Rouge, LA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 6/21/2017
2576
mi
from 02139
San Diego, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 6/21/2017
1411
mi
from 02139
Shreveport, LA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 6/21/2017
639
mi
from 02139
Toledo, OH
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 6/21/2017
2600
mi
from 02139
Torrance, CA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology Clinical Trial
Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)
Status: Enrolling, Phase III
Updated: 12/31/1969
2044
mi
from 02139
Butte, MT
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology Clinical Trial
Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)
Status: Enrolling, Phase III
Updated: 12/31/1969
2576
mi
from 02139
San Diego, CA
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling, Phase I
Updated: 4/12/2016
846
mi
from 02139
Chicago, IL
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling, Phase I
Updated: 4/12/2016
4605
mi
from 02139
Plovdiv,
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling, Phase I
Updated: 4/12/2016
2576
mi
from 02139
San Diego, CA
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling, Phase I
Updated: 4/12/2016
2481
mi
from 02139
Seattle, WA
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling, Phase I
Updated: 4/12/2016
1411
mi
from 02139
Shreveport, LA
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases Clinical Trial
Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections
Status: Enrolling, Phase III
Updated: 12/31/1969
499
mi
from 02139
Youngstown, OH
Click here to add this to my saved trials
Hepatitis C Virus Infection Clinical Trial
A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
Status: Enrolling, Phase
Updated: 12/31/1969
2589
mi
from 02139
Los Angeles, CA
Click here to add this to my saved trials
Hepatitis C Virus Infection Clinical Trial
A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
Status: Enrolling, Phase
Updated: 12/31/1969
497
mi
from 02139
Morgantown, WV
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling, Phase I, II
Updated: 2/4/2016
1596
mi
from 02139
Galveston, TX
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling, Phase I, II
Updated: 2/4/2016
1769
mi
from 02139
San Antonio, TX
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling, Phase I, II
Updated: 2/4/2016
2576
mi
from 02139
San Diego, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL
Status: Enrolling, Phase I
Updated: 12/31/1969
405
mi
from 02139
Fairfax, VA
Click here to add this to my saved trials
Gonorrhea Clinical Trial
A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae
Status: Enrolling, Phase II
Updated: 3/24/2016
1682
mi
from 02139
San Juan,
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Project: Every Child for Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
2586
mi
from 02139
Downey, CA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Project: Every Child for Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
1078
mi
from 02139
Gainesville, FL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Project: Every Child for Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
859
mi
from 02139
Green Bay, WI
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Project: Every Child for Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
2366
mi
from 02139
Las Vegas, NV
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Project: Every Child for Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
172
mi
from 02139
Mineola, NY
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Project: Every Child for Younger Patients With Cancer
Status: Enrolling, Phase
Updated: 12/31/1969
140
mi
from 02139
New York, NY
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling, Phase III
Updated: 4/14/2016
1569
mi
from 02139
Arlington, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling, Phase III
Updated: 4/14/2016
616
mi
from 02139
Chapel Hill, NC
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling, Phase III
Updated: 4/14/2016
1153
mi
from 02139
Fort Pierce, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
357
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
2578
mi
from 02139
Coronado, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
1546
mi
from 02139
Dallas, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
1076
mi
from 02139
Gainesville, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
225
mi
from 02139
Hillsborough, NJ
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
2550
mi
from 02139
La Jolla, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
469
mi
from 02139
Richmond, VA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
1115
mi
from 02139
St. Paul, MN
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling, Phase III
Updated: 6/13/2016
1021
mi
from 02139
Columbus, GA
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling, Phase III
Updated: 6/13/2016
1092
mi
from 02139
Debary, FL
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling, Phase III
Updated: 6/13/2016
1240
mi
from 02139
Hollywood, FL
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling, Phase III
Updated: 6/13/2016
653
mi
from 02139
Royal Oaks, MI
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling, Phase III
Updated: 6/13/2016
278
mi
from 02139
Somers Point, NJ
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling, Phase III
Updated: 6/13/2016
1034
mi
from 02139
St. Louis, MO
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling, Phase III
Updated: 6/13/2016
2591
mi
from 02139
Sylmar, CA
Click here to add this to my saved trials
Adenovirus Clinical Trial
Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Status: Enrolling, Phase
Updated: 12/31/1969
1
mi
from 02139
Boston, MA
Click here to add this to my saved trials
Adenovirus Clinical Trial
Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Status: Enrolling, Phase
Updated: 12/31/1969
183
mi
from 02139
Hackensack, NJ
Click here to add this to my saved trials
Adenovirus Clinical Trial
Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
Status: Enrolling, Phase
Updated: 12/31/1969
1605
mi
from 02139
Houston, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 4/13/2016
643
mi
from 02139
Ann Arbor, MI
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 4/13/2016
1378
mi
from 02139
Baton Rouge, LA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 4/13/2016
1276
mi
from 02139
Omaha, NE
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 4/13/2016
639
mi
from 02139
Toledo, OH
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling, Phase I
Updated: 4/13/2016
2600
mi
from 02139
Torrance, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Reproductive Clinical Trial
Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens
Status: Enrolling
Updated: 12/31/1969
287
mi
from 02139
West Reading, PA
Click here to add this to my saved trials
Adenovirus Clinical Trial
A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304
Status: Enrolling
Updated: 2/25/2016
732
mi
from 02139
Cincinnati, OH
Click here to add this to my saved trials
Clostridium Difficile Infection Clinical Trial
Expanded Access and Open Label Extension Study of SER-109 to Prevent Recurrent Clostridium Difficile Infection
Status: Enrolling, Phase II
Updated: 5/26/2016
140
mi
from 02139
New York, NY
Click here to add this to my saved trials
Clostridium Difficile Infection Clinical Trial
Expanded Access and Open Label Extension Study of SER-109 to Prevent Recurrent Clostridium Difficile Infection
Status: Enrolling, Phase II
Updated: 5/26/2016
2630
mi
from 02139
Ventura, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
2576
mi
from 02139
San Diego, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
2481
mi
from 02139
Seattle, WA
Click here to add this to my saved trials
Cough Clinical Trial
Dextromethorphan Pediatric Acute Cough Study
Status: Enrolling, Phase IV
Updated: 12/31/1969
820
mi
from 02139
Charleston, SC
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension
Status: Enrolling, Phase II
Updated: 12/31/1969
3470
mi
from 02139
Brussels,
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
646
mi
from 02139
Brighton, MI
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
658
mi
from 02139
Chelsea, MI
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
1120
mi
from 02139
Collierville, TN
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
1675
mi
from 02139
Manati,
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
1108
mi
from 02139
New Albany, MS
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
Status: Enrolling
Updated: 12/31/1969
287
mi
from 02139
Pottsville, PA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection
Status: Enrolling, Phase I
Updated: 12/31/1969
1684
mi
from 02139
San Juan,
Click here to add this to my saved trials
Gram-Positive Bacterial Infections Clinical Trial
A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to
Status: Enrolling, Phase I
Updated: 12/31/1969
1574
mi
from 02139
Fort Worth, TX
Click here to add this to my saved trials
Gram-Positive Bacterial Infections Clinical Trial
A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to
Status: Enrolling, Phase I
Updated: 12/31/1969
1601
mi
from 02139
Houston, TX
Click here to add this to my saved trials
Gram-Positive Bacterial Infections Clinical Trial
A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to
Status: Enrolling, Phase I
Updated: 12/31/1969
1245
mi
from 02139
Kansas City, MO
Click here to add this to my saved trials
Gram-Positive Bacterial Infections Clinical Trial
A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to
Status: Enrolling, Phase I
Updated: 12/31/1969
1254
mi
from 02139
Little Rock, AR
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Immunogenicity of a Quadrivalent Virus-Like Particles (VLP) Influenza Vaccine in Healthy Adults
Status: Enrolling, Phase II
Updated: 7/11/2016
1263
mi
from 02139
South Miami, FL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
398
mi
from 02139
Annadale, VA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
2
mi
from 02139
Boston, MA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
846
mi
from 02139
Chicago, IL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
736
mi
from 02139
Cincinnati, OH
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1763
mi
from 02139
Denver, CO
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
2584
mi
from 02139
Glendale, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1240
mi
from 02139
Hollywood, FL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1601
mi
from 02139
Houston, TX
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1255
mi
from 02139
Little Rock, AR
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1187
mi
from 02139
North Palm Beach, FL
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
76
mi
from 02139
Norwich, CT
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
2690
mi
from 02139
San Rafael, CA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
234
mi
from 02139
Sommers Point, NJ
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
2256
mi
from 02139
Spokane, WA
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
1034
mi
from 02139
St. Louis, MO
Click here to add this to my saved trials
Fasciitis, Plantar Clinical Trial
ReNu™ vs. Corticosteroids for the Treatment of Plantar Fasciitis
Status: Enrolling
Updated: 12/31/1969
1160
mi
from 02139
West Des Moines, IA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Expanded Access Protocol for Tabelecleucel in Subjects With EBV-Associated Viremia or Malignancies
Status: Enrolling, Phase
Updated: 12/31/1969
640
mi
from 02139
Columbus, OH
Click here to add this to my saved trials
HIV INfections Clinical Trial
Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 Infection
Status: Enrolling, Phase I
Updated: 12/31/1969
2574
mi
from 02139
La Jolla, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Status: Enrolling, Phase
Updated: 12/31/1969
5378
mi
from 02139
Buenos Aires,
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
939
mi
from 02139
Nashville, TN
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
1769
mi
from 02139
San Antonio, TX
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
1601
mi
from 02139
Houston, TX
Click here to add this to my saved trials
1 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 65